HuGE Literature Finder
Records
1
-
4
MassArray analysis of genomic susceptibility variants in ovarian cancer. Scientific reports 2020 12 10 (1): 21101. Verma Sonali, Sharma Indu, Sharma Varun, Bhat Amrita, Shah Ruchi, Bhat Gh Rasool, Sharma Bhanu, Bakshi Divya, Nagpal Ashna, Wakhloo Ajay, Bhat Audesh, Kumar Rake |
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer. Pharmacogenomics 2014 Feb 15 (3): 329-37. Khrunin Andrey V, Khokhrin Denis V, Moisseev Alexey A, Gorbunova Vera A, Limborska Svetlana |
Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer. Cancer 2012 Feb 118 (3): 689-97. Fleming Nicole D, Agadjanian Hasmik, Nassanian Hoorig, Miller Carl W, Orsulic Sandra, Karlan Beth Y, Walsh Christine |
Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 Feb 15 (2): 306-11. Huang Wen-Yi, Berndt Sonja I, Kang Daehee, Chatterjee Nilanjan, Chanock Stephen J, Yeager Meredith, Welch Robert, Bresalier Robert S, Weissfeld Joel L, Hayes Richard |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: